杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/06/02 | 1,534 | 1,541 | 1,526 | 1,535 | -10 | -0.6% | 108,000 |
2011/06/01 | 1,530 | 1,545 | 1,526 | 1,545 | +15 | +1% | 187,000 |
2011/05/31 | 1,545 | 1,547 | 1,530 | 1,530 | -14 | -0.9% | 271,000 |
2011/05/30 | 1,530 | 1,545 | 1,520 | 1,544 | +7 | +0.5% | 86,000 |
2011/05/27 | 1,543 | 1,545 | 1,534 | 1,537 | -8 | -0.5% | 114,000 |
2011/05/26 | 1,550 | 1,564 | 1,541 | 1,545 | -8 | -0.5% | 193,000 |
2011/05/25 | 1,550 | 1,555 | 1,530 | 1,553 | +23 | +1.5% | 221,000 |
2011/05/24 | 1,506 | 1,530 | 1,500 | 1,530 | +24 | +1.6% | 147,000 |
2011/05/23 | 1,493 | 1,514 | 1,484 | 1,506 | +13 | +0.9% | 215,000 |
2011/05/20 | 1,489 | 1,508 | 1,485 | 1,493 | -15 | -1% | 182,000 |
2011/05/19 | 1,488 | 1,516 | 1,480 | 1,508 | +20 | +1.3% | 294,000 |
2011/05/18 | 1,484 | 1,502 | 1,484 | 1,488 | +3 | +0.2% | 122,000 |
2011/05/17 | 1,484 | 1,491 | 1,479 | 1,485 | +9 | +0.6% | 171,000 |
2011/05/16 | 1,464 | 1,489 | 1,464 | 1,476 | -3 | -0.2% | 111,000 |
2011/05/13 | 1,506 | 1,506 | 1,473 | 1,479 | -19 | -1.3% | 129,000 |
2011/05/12 | 1,488 | 1,511 | 1,474 | 1,498 | +8 | +0.5% | 274,000 |
2011/05/11 | 1,500 | 1,500 | 1,471 | 1,490 | +3 | +0.2% | 149,000 |
2011/05/10 | 1,489 | 1,494 | 1,484 | 1,487 | ±0 | ±0% | 108,000 |
2011/05/09 | 1,494 | 1,501 | 1,483 | 1,487 | +3 | +0.2% | 199,000 |
2011/05/06 | 1,479 | 1,492 | 1,477 | 1,484 | +5 | +0.3% | 162,000 |
2011/05/02 | 1,449 | 1,485 | 1,445 | 1,479 | +34 | +2.4% | 211,000 |
2011/04/28 | 1,409 | 1,447 | 1,405 | 1,445 | +43 | +3.1% | 191,000 |
2011/04/27 | 1,405 | 1,415 | 1,388 | 1,402 | -3 | -0.2% | 198,000 |
2011/04/26 | 1,423 | 1,423 | 1,398 | 1,405 | -18 | -1.3% | 152,000 |
2011/04/25 | 1,452 | 1,455 | 1,419 | 1,423 | +1 | +0.1% | 168,000 |
2011/04/22 | 1,422 | 1,431 | 1,419 | 1,422 | +1 | +0.1% | 139,000 |
2011/04/21 | 1,422 | 1,426 | 1,413 | 1,421 | +1 | +0.1% | 99,000 |
2011/04/20 | 1,406 | 1,434 | 1,406 | 1,420 | +16 | +1.1% | 95,000 |
2011/04/19 | 1,401 | 1,414 | 1,400 | 1,404 | -16 | -1.1% | 98,000 |
2011/04/18 | 1,433 | 1,440 | 1,418 | 1,420 | -5 | -0.4% | 100,000 |
2011/04/15 | 1,415 | 1,432 | 1,410 | 1,425 | +15 | +1.1% | 193,000 |
2011/04/14 | 1,404 | 1,419 | 1,391 | 1,410 | +2 | +0.1% | 147,000 |
2011/04/13 | 1,398 | 1,414 | 1,398 | 1,408 | +8 | +0.6% | 54,000 |
2011/04/12 | 1,403 | 1,414 | 1,395 | 1,400 | -16 | -1.1% | 119,000 |
2011/04/11 | 1,415 | 1,424 | 1,397 | 1,416 | +18 | +1.3% | 231,000 |
2011/04/08 | 1,372 | 1,409 | 1,371 | 1,398 | +27 | +2% | 167,000 |
2011/04/07 | 1,370 | 1,388 | 1,364 | 1,371 | +3 | +0.2% | 233,000 |
2011/04/06 | 1,401 | 1,404 | 1,362 | 1,368 | -22 | -1.6% | 296,000 |
2011/04/05 | 1,406 | 1,408 | 1,379 | 1,390 | -9 | -0.6% | 154,000 |
2011/04/04 | 1,402 | 1,412 | 1,393 | 1,399 | -10 | -0.7% | 163,000 |
2011/04/01 | 1,422 | 1,430 | 1,401 | 1,409 | -7 | -0.5% | 181,000 |
2011/03/31 | 1,418 | 1,418 | 1,402 | 1,416 | +2 | +0.1% | 165,000 |
2011/03/30 | 1,388 | 1,414 | 1,381 | 1,414 | +16 | +1.1% | 207,000 |
2011/03/29 | 1,413 | 1,413 | 1,387 | 1,398 | -15 | -1.1% | 192,000 |
2011/03/28 | 1,436 | 1,436 | 1,400 | 1,413 | -12 | -0.8% | 131,000 |
2011/03/25 | 1,445 | 1,445 | 1,400 | 1,425 | +6 | +0.4% | 147,000 |
2011/03/24 | 1,381 | 1,421 | 1,372 | 1,419 | +25 | +1.8% | 255,000 |
2011/03/23 | 1,408 | 1,424 | 1,382 | 1,394 | -13 | -0.9% | 164,000 |
2011/03/22 | 1,396 | 1,407 | 1,390 | 1,407 | +41 | +3% | 160,000 |
2011/03/18 | 1,359 | 1,383 | 1,340 | 1,366 | +11 | +0.8% | 251,000 |
3301~
3350
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム